The spasticity landscape offers opportunities with over 10 companies and 12 pipeline drugs in development. Key prospects lie in novel therapies like Motric Bio's MTR-601 and Ipsen's IPN10200. Focused ...

Sativex, a cannabis-based spray for MS spasticity, was bought by CNX Therapeutics. It's used as an add-on therapy in Europe ...

UK-based specialty CNS-focused pharma company CNX Therapeutics says it has acquired the global Sativex (nabiximols) business from USA-based Jazz Pharmaceuticals.

Sativex is indicated for symptom improvement in adult patients with moderate to severe spasticity. Inflexion portfolio company CNX Therapeutics has acquired the global Sativex business from Jazz ...

Using cryotherapy guided by non-invasive ultrasound, Victoria doctors are helping patients with spasticity to unlock their ...